Cosmo Bio Company,Limited
Research Cosmo Bio Company,Limited (3386.T) on Bullrun: market cap JPY 7.12B, P/E 19.5, dividend yield 4.0%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker3386.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyJPY
- Market capJPY 7.12B
- P/E19.5
- Dividend yield4.0%
- Financial periodFY2025
- RevenueJPY 10.77B
- Revenue growth7.3%
- Net incomeJPY 337.00M
- Free cash flowJPY 314.00M
- Gross margin34.4%
Valuation Snapshot
latest market cap is JPY 7.12B; P/E is 19.5; dividend yield is 4.0%.
Peer valuation comparison
Latest P/E is 19.53x versus a Healthcare sector median of 21.69x (9.9% below).
Latest dividend yield is 4.02% versus a Healthcare sector median of 2.41% (66.8% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | JPY 10.77B | JPY 337.00M | JPY 314.00M | 34.4% | 59.26 | JPY 2.75B | JPY 20.00M | JPY 9.37B |
| FY2024 | JPY 10.04B | JPY 262.00M | -JPY 35.00M | 33.2% | 45.05 | JPY 2.39B | JPY 20.00M | JPY 8.97B |
| FY2023 | JPY 9.34B | JPY 442.00M | JPY 636.00M | 34.8% | 75.97 | JPY 2.83B | JPY 20.00M | JPY 8.44B |
| FY2022 | JPY 9.55B | JPY 517.00M | JPY 180.00M | 36.0% | 89.13 | JPY 3.04B | JPY 20.00M | JPY 8.05B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 7.12B | 19.5 | 4.0% | 50 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 50 JPY, yield 4.0%.
| Year | Dividends/share |
|---|---|
| FY2025 | 50 JPY |
| FY2024 | 50 JPY |
| FY2023 | 30 JPY |
| FY2022 | 36 JPY |
About Cosmo Bio Company,Limited
Cosmo Bio Company,Limited, together with its subsidiaries, operates as a life science trading company worldwide. It is involved in the import, export, manufacture, marketing, sales, and customer support of life science research bio tools, such as reagents, kits, instruments, and software.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Cosmo Bio Company,Limited's market cap?
Cosmo Bio Company,Limited's market capitalization is JPY 7.12B.
What is Cosmo Bio Company,Limited's P/E ratio?
Cosmo Bio Company,Limited's price-to-earnings (P/E) ratio is 19.5.
Does Cosmo Bio Company,Limited pay a dividend?
Cosmo Bio Company,Limited has a dividend yield of 4.0%.
What does Cosmo Bio Company,Limited do?
Cosmo Bio Company,Limited, together with its subsidiaries, operates as a life science trading company worldwide. It is involved in the import, export, manufacture, marketing, sales, and customer support of life science research bio tools, such as reagents, kits, instruments, and software.